Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.

Articles

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
DOJ Brings COVID-19-Related Fraud Charges Against Tech Company President
Challenge to Expert Witness Testimony Better Left for Cross; United States District Court for the District of Utah No. 2:16-CV-304 TS, U.S. ex rel. Gerald Polukoff M.D. v. St. Mark’s Hospital et al.
Plaintiff Alleged No Connection Between Termination by Current Employer and Retaliation by Defendant; United States Court of Appeals for the Fourth Circuit No. 19-1243, U.S. ex rel. Complin v. North Carolina Baptist Hospital et al.
Business Tax Documents Fair Game in AKS Complaint; United States District Court for the District of Kansas No. 17-cv-02395-EFM-GEB, U.S. ex rel. Mona Sabet Edalati, et al. v. Minimally Invasive Surgery Hospital Inc., et al.
Cochise Ruling Sends Dismissed Qui Tam Complaint Back to District Court for Review Under 10-Year Statute of Limitations; United States Court of Appeals for the Tenth Circuit No. 18-4109, U.S. ex rel. Mark Christopher Tracy v. Emigration Improvement District, et al.
Relator Fails to Support Healthcare Fraud Allegations With Facts; United States District Court for the Northern District of Illinois, Eastern Division No. 17 C 6638, U.S. and the State of Illinois ex rel. Thomas Prose v. Molina Healthcare of Illinois Inc. and Molina Healthcare Inc.
Fifth Circuit Affirms Dismissal of FCA Case Based on Inadequate Pleading of Upcoded Claims
DOJ Announces Almost $25 Million in Recent FCA Settlements
DOJ Emphasizes Data-Driven Approach to Monitoring and Importance of Culture in Latest Adjustments to Corporate Compliance Program Guidance
Compliance Programs Must Track and Adapt to Changes and Risks
Department of Justice’s 2020 Update Moves the Needle on Guidance for Evaluation of Corporate Compliance Programs
Strategic Litigation Choices, Not Government Delay, Pushed Qui Tam Suit Outside Statute of Limitations; United States District Court for the Southern District of New York No. 19-CV-4029 (JMF), U.S. ex rel. John A. Wood, et al. v Allergan Inc.
Prepare for a Perfect Storm of COVID-19 Whistleblower Claims
Whose Knowledge Counts? The Expanding Scope of Government Knowledge in FCA Cases
Attempt to Relitigate Summary Judgment Issues Fails to Raise Extraordinary Circumstance for Interlocutory Review; United States District Court for the District of Minnesota No. 08-1194 (DWF/HB), U.S. ex rel. Ricia Johnson and Health Dimensions Rehabilitation Inc. v. Golden Gate National Senior Care LLC, et al.
Materiality Concerns For CARES Act Enforcement Cases
Public Disclosure Bar Jurisdictional, Regardless of Other Pleading Deficiencies; United States Court of Appeals for the Second Circuit, No. 18-3376, U.S. ex rel. Don Hanks v. Florida Cancer Specialists, et al.
Experience With Specific Medical Procedures Not Only Avenue to Determining Expertise of Relator’s Witnesses; United States District Court for the District of Utah, No. 2:16-CV-304 TS, U.S. ex rel. Gerald Polukoff M.D. v. St. Mark’s Hospital, et al.
Senate Judiciary Committee Hearing Highlights COVID-19 Enforcement Trends and Priorities
Keep reading


